There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:DISEASE
Pages in category "DISEASE"
The following 200 pages are in this category, out of 792 total.
(previous page) (next page)A
- BRST5:Acinic cell carcinoma
- STBT5:Acral fibromyxoma
- GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)
- HAEM5:Acute basophilic leukaemia
- HAEM4:Acute Basophilic Leukemia
- HAEM5:Acute erythroid leukaemia
- HAEM5:Acute leukaemia of ambiguous lineage with other defined genetic alterations
- HAEM5:Acute leukaemia of ambiguous lineage, NOS
- HAEM5:Acute megakaryoblastic leukaemia
- HAEM4:Acute Megakaryoblastic Leukemia (AMKL)
- HAEM4:Acute Monoblastic and Monocytic Leukemia
- HAEM5:Acute monocytic leukaemia
- HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion
- HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion
- HAEM5:Acute myeloid leukaemia with CEBPA mutation
- HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion
- HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation
- HAEM5:Acute myeloid leukaemia with KMT2A rearrangement
- HAEM5:Acute myeloid leukaemia with maturation
- HAEM5:Acute myeloid leukaemia with MECOM rearrangement
- HAEM5:Acute myeloid leukaemia with minimal differentiation
- HAEM5:Acute myeloid leukaemia with NPM1 mutation
- HAEM5:Acute myeloid leukaemia with NUP98 rearrangement
- HAEM5:Acute myeloid leukaemia with other defined genetic alterations
- HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion
- HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion
- HAEM5:Acute myeloid leukaemia without maturation
- HAEM5:Acute myeloid leukaemia, myelodysplasia-related
- HAEM4:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1
- HAEM4:Acute Myeloid Leukemia (AML) with BCR-ABL1
- HAEM4:Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA
- HAEM4:Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
- HAEM4:Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM
- HAEM4:Acute Myeloid Leukemia (AML) with Maturation
- HAEM4:Acute Myeloid Leukemia (AML) with Minimal Differentiation
- HAEM4:Acute Myeloid Leukemia (AML) with Mutated FLT3
- HAEM4:Acute Myeloid Leukemia (AML) with Mutated NPM1
- HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1
- HAEM4:Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes
- HAEM4:Acute Myeloid Leukemia (AML) with NUP214-ABL1
- HAEM4:Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
- HAEM4:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214
- HAEM4:Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
- HAEM4:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
- HAEM4:Acute Myeloid Leukemia (AML) without Maturation
- HAEM5:Acute myelomonocytic leukaemia
- HAEM4:Acute Myelomonocytic Leukemia
- HAEM4:Acute Panmyelosis with Myelofibrosis
- HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion
- HAEM4:Acute Promyelocytic Leukemia (APL) with PML-RARA
- HAEM5:Acute undifferentiated leukaemia
- HAEM4:Acute Undifferentiated Leukemia
- STBT5:Adamantinoma of long bones
- CNS5:Adamantinomatous craniopharyngioma
- BRST5:Adenoid cystic carcinoma
- BRST5:Adenomyoepithelioma
- STBT5:Adult fibrosarcoma
- HAEM5:Adult T-cell leukaemia/lymphoma
- HAEM4:Adult T-cell Leukemia/Lymphoma
- HAEM5:Aggressive NK-cell leukaemia
- HAEM4:Aggressive NK-cell Leukemia
- HAEM5:ALK-negative anaplastic large cell lymphoma
- HAEM5:ALK-positive histiocytosis
- HAEM4:ALK-Positive Large B-cell Lymphoma
- HAEM5:ALK-positive large B-cell lymphoma
- HAEM5:Alpha heavy chain disease
- STBT5:Alveolar rhabdomyosarcoma
- STBT5:Alveolar soft part sarcoma
- CNS5:Anaplastic large cell lymphoma (ALK+/ALK−)
- HAEM4:Anaplastic Large Cell Lymphoma, ALK-Negative
- HAEM4:Anaplastic Large Cell Lymphoma, ALK-Positive
- STBT5:Anastomosing haemangioma
- STBT5:Aneurysmal bone cyst
- CNS5:Angiocentric glioma
- STBT5:Angiofibroma of soft tissue
- HAEM4:Angioimmunoblastic T-cell Lymphoma
- STBT5:Angioleiomyoma
- BRST5:Angiolipoma
- STBT5:Angiolipoma
- STBT5:Angiomatoid fibrous histiocytoma
- BRST5:Angiomatosis
- STBT5:Angiomyofibroblastoma
- STBT5:Angiosarcoma
- STBT5:Angiosarcoma of bone
- BRST5:Apocrine adenosis and adenoma
- STBT5:Arteriovenous malformation/haemangioma
- CNS5:Astroblastoma, MN1-altered
- CNS5:Astrocytoma, IDH-mutant
- GTS5:Ataxia-telangiectasia syndrome (ATM)
- CNS5:Atypical choroid plexus papilloma
- HAEM4:Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative
- BRST5:Atypical ductal hyperplasia
- STBT5:Atypical fibroxanthoma
- STBT5:Atypical lipomatous tumour / well-differentiated liposarcoma
- BRST5:Atypical lobular hyperplasia
- STBT5:Atypical spindle cell / pleomorphic lipomatous tumour
- CNS5:Atypical teratoid/rhabdoid tumour
- BRST5:Atypical vascular lesions
- HAEM5:Autoimmune lymphoproliferative syndrome
- GTS5:Autoimmune lymphoproliferative syndrome (FAS)
- GTS5:AXIN2-associated polyposis (AXIN2)
B
- HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
- HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
- HAEM5:B-lymphoblastic leukaemia/lymphoma
- HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
- HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
- HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features
- HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
- HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy
- HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21
- HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
- HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with iAMP21
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
- GTS5:BAP1-related tumour predisposition syndrome (BAP1)
- GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)
- STBT5:Benign notochordal cell tumour
- STBT5:Benign triton tumour / neuromuscular choristoma
- GTS5:Birt-Hogg-Dube syndrome (FLCN)
- STBT5:Bizarre parosteal osteochondromatous proliferation
- HAEM4:Blastic Plasmacytoid Dendritic Cell Neoplasm
- HAEM5:Blastic plasmacytoid dendritic cell neoplasm
- HAEM5:Bloom syndrome
- GTS5:Bloom syndrome (BLM)
- STBT5:Bone metastases
- GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)
- HAEM4:Breast Implant-Associated Anaplastic Large Cell Lymphoma
- HAEM5:Breast implant-associated anaplastic large cell lymphoma
- BRST5:Breast implant-associated anaplastic large cell lymphoma
- GTS5:Brooke-Spiegler syndrome (CYLD)
- HAEM4:Burkitt Lymphoma
- HAEM5:Burkitt lymphoma
- BRST5:Burkitt lymphoma
- HAEM4:Burkitt-Like Lymphoma with 11q Aberration
C
- STBT5:Calcifying aponeurotic fibroma
- BRST5:Carcinoma in situ
- BRST5:Carcinoma with apocrine differentiation
- GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)
- CNS5:Cauda equina neuroendocrine tumour (previously paraganglioma)
- GTS5:CDK4-related melanoma predisposition syndrome (CDK4)
- GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)
- STBT5:Cellular angiofibroma
- STBT5:Central atypical cartilaginous tumour / chondrosarcoma, grade 1
- STBT5:Central chondrosarcoma, grades 2 and 3
- CNS5:Central neurocytoma
- CNS5:Cerebellar liponeurocytoma
- GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)
- HAEM5:Childhood myelodysplastic neoplasm with increased blasts
- HAEM5:Childhood myelodysplastic neoplasm with low blasts
- STBT5:Chondroblastoma
- STBT5:Chondroid lipoma
- STBT5:Chondromesenchymal hamartoma of chest wall
- STBT5:Chondromyxoid fibroma
- CNS5:Chondrosarcoma
- CNS5:Chordoid glioma
- CNS5:Chordoma
- CNS5:Choroid plexus carcinoma
- CNS5:Choroid plexus papilloma
- HAEM5:Chronic eosinophilic leukaemia
- HAEM4:Chronic Eosinophilic Leukemia, Not Otherwise Specified
- HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma
- HAEM4:Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- HAEM4:Chronic Lymphoproliferative Disorder of NK Cells
- HAEM5:Chronic myeloid leukaemia
- HAEM4:Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
- HAEM5:Chronic myelomonocytic leukaemia
- HAEM4:Chronic Myelomonocytic Leukemia (CMML)
- HAEM5:Chronic neutrophilic leukaemia
- HAEM4:Chronic Neutrophilic Leukemia (CNL)
- STBT5:CIC-rearranged sarcoma
- CNS5:CIC-rearranged sarcoma
- CNS5:Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma
- HAEM5:Classic Hodgkin lymphoma
- STBT5:Clear cell chondrosarcoma
- GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)
- STBT5:Clear cell sarcoma of soft tissue
- HAEM5:Clonal cytopenias of undetermined significance
- HAEM5:Clonal haematopoiesis
- CNS5:CNS embryonal tumour NEC/NOS
- CNS5:CNS neuroblastoma, FOXR2-activated
- CNS5:CNS tumour with BCOR internal tandem duplication
- HAEM5:Cold agglutinin disease
- BRST5:Columnar cell lesions, including flat epithelial atypia
- STBT5:Composite haemangioendothelioma